AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOMARIN PHARMACEUTICAL INC Director's Dealing 2014

Nov 5, 2014

30583_dirs_2014-11-05_d3536645-0b03-4dbb-8991-f0596443f339.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-10-31

Reporting Person: Ajer Jeffrey Robert (SVP, Chief Commercial Of)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-10-31	Common Stock	A	47	$31.26	Acquired	31637	Direct
2014-11-03	Common Stock	S	47	$83.54	Disposed	31590	Direct

Footnotes

F1: The reporting person is reporting the purchase of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of May 1, 2014 to October 31, 2014.

F2: Transaction made pursuant to a Rule 10b5-1 trading plan executed on December 12, 2013.

F3: All shares sold at same price